SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-140685
Filing Date
2020-12-31
Accepted
2020-12-31 06:04:40
Documents
1
Group Members
2019B CAYMAN LTDCCP IV GP LTD.CITIC CAPITAL CHINA PARTNERS IV, L.P.CITIC CAPITAL PARTNERS LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm2039672d1_sc13da.htm SC 13D/A 106016
  Complete submission text file 0001104659-20-140685.txt   107993
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products Holdings, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 201427438
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000
Business Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000 852-3710-6888
CITIC Capital Holdings Ltd (Filed by) CIK: 0001677151 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A